Vineet Laboratories Limited

NSE VINEETLAB.NS

Vineet Laboratories Limited Debt to Equity Ratio for the year ending March 31, 2024: 1.28

Vineet Laboratories Limited Debt to Equity Ratio is 1.28 for the year ending March 31, 2024, a 38.22% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Vineet Laboratories Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.92, a -0.14% change year over year.
Vineet Laboratories Limited Debt to Equity Ratio for the year ending March 31, 2022 was 0.92, a 33.65% change year over year.
Vineet Laboratories Limited Debt to Equity Ratio for the year ending March 31, 2021 was 0.69.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

NSE: VINEETLAB.NS

Vineet Laboratories Limited

CEO	Mr. Gaddam Venkata Ramana
IPO Date	June 15, 2021
Location	India
Headquarters	5-5-160, Malleswari Nilayam
Employees	79
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Petrochemicals

Description

Vineet Laboratories Limited engages in the research, development, and manufacture of active pharmaceutical ingredients and fine chemicals in India. The company was incorporated in 2016 and is based in Hyderabad, India.

Key trends

Past 5 years